Basivertebral Nerve Ablation for Chronic Low Back Pain
Chronic low back pain can be frustrating, exhausting, and life-limiting — especially when it persists despite physical therapy, medications, or injections. For some patients, the source of pain is not the muscles or discs alone, but the vertebral bones of the spine themselves. In these cases, basivertebral nerve ablation may offer a meaningful and lasting treatment option.
THE BASICS
What Is Basivertebral Nerve Ablation — and How Is It Different?
Not all low back pain comes from the same place. In a subset of patients, pain originates from within the vertebral bodies rather than from a pinched nerve or surrounding soft tissue. Small pain-sensing nerves embedded within the bone — the basivertebral nerves — detect these changes and generate a persistent, deep, aching pain that typically worsens with sitting, bending, or prolonged activity. On MRI, this pattern is often associated with Modic Type I or Type II endplate changes, signal alterations that reflect the underlying biology driving the pain. This type of pain does not respond reliably to injections targeting the facet joints or surrounding nerves, because the pain generator is not there. That is the clinical problem basivertebral nerve ablation is designed to solve.
Basivertebral nerve ablation is a minimally invasive outpatient procedure that uses controlled radiofrequency energy to interrupt the nerve signals responsible for this specific form of chronic low back pain. It is performed through a small access point in the skin using advanced imaging guidance, without placing any permanent hardware in the spine. The goal is not to mask pain but to address the underlying signal at its source.
KEY DISTINCTION
Unlike epidural steroid injections or medial branch blocks, which target the space around the spine or the facet joints, basivertebral nerve ablation targets the pain generator inside the vertebral body itself. Unlike spinal fusion, it involves no implants, no significant tissue disruption, and no prolonged recovery. It is not a replacement for surgery when surgery is truly indicated — it is a precision tool for a specific diagnosis that surgery was never well-suited to address in the first place.
FDA-cleared systems are available to perform this procedure, including the Boston Scientific Intracept® system and newer platforms such as the Stryker OptaBlate® BVN. The technology matters, but it is secondary to the most important variable in any interventional decision: patient selection.
DURATION
How Long Does Relief Actually Last?
The durability of basivertebral nerve ablation is one of its most clinically compelling features. The pivotal SMART trial and its long-term follow-up demonstrated sustained, statistically significant improvements in pain and function that have been maintained out to five years in treated patients. This is not a temporary block or a short-cycle injection — the ablation of the basivertebral nerve produces lasting interruption of the intraosseous pain signal, and because the nerve does not regenerate along the same pathway in the same way peripheral nerves do, the durability profile is fundamentally different from other ablative approaches in the spine.
CLINICAL EVIDENCE
What Does the Research Show?
The evidence base supporting basivertebral nerve ablation is among the strongest in the interventional spine space. The SMART trial — a randomized, double-blind, sham-controlled study — demonstrated statistically significant improvements in pain (VAS) and function (ODI) at six months, with the sham group subsequently crossing over to active treatment and showing comparable benefit. Long-term registry data from Fischgrund et al. and Becker et al. have confirmed durable outcomes at two and five years respectively, with clinically meaningful reductions in both pain scores and disability indices maintained across the follow-up period. Comparative effectiveness data suggest that BVNA outperforms standard care, including physical therapy and injections, in patients with confirmed Modic changes — and does so with a safety profile consistent with other minimally invasive outpatient spine procedures.
PATIENT SELECTION
Who Is a Good Candidate?
Patient selection is the most important determinant of outcome with basivertebral nerve ablation, and it is where I spend the most time in the evaluation process. The right candidate has had chronic low back pain for six months or longer, has not achieved lasting relief with conservative treatments including physical therapy and injections, has MRI findings consistent with Modic Type I or Type II endplate changes at one or more lumbar levels, and does not require urgent surgical intervention for instability, deformity, or neurological compromise. This is not a procedure I offer broadly. It is one I recommend when the diagnosis fits, the imaging supports it, and the patient's goals align with what the evidence shows this treatment can realistically deliver. A thorough clinical evaluation and careful imaging review are essential before any recommendation is made.
The procedure is performed on an outpatient basis under sedation. Most patients go home the same day and resume normal activities gradually under guidance. Because there are no implants and minimal tissue disruption, recovery is typically straightforward compared to surgical alternatives.
FOR REFERRING CLINICIANS
Basivertebral nerve ablation is increasingly recognized as an important option in the management of chronic axial low back pain driven by vertebral endplate pathology. Appropriate referral candidates include patients with chronic low back pain of six months or greater duration who have failed conservative management and have MRI findings consistent with Modic Type I or II changes; patients who have had an inadequate response to epidural or facet-based interventions; and patients for whom surgical options have been discussed but who prefer or require a non-implant, minimally invasive alternative. I welcome direct physician-to-physician consultation.
PERSPECTIVE
A Note on Where This Fits in Modern Spine Care
Chronic low back pain is the leading cause of disability in the United States, and the gap between how common it is and how well we treat it remains wide. For too long, the options have been framed as a binary — conservative care on one end, surgery on the other — with a middle ground defined largely by injections that were never designed to be curative. Basivertebral nerve ablation occupies a different position in that landscape. It is not a bridge to surgery. It is not a temporizing measure. For the right patient, it is a definitive treatment for a specific and underdiagnosed pain generator that has been responsible for years of suffering without a name.
I am particularly interested in identifying these patients early — before they have accumulated years of failed treatments, before their function has deteriorated significantly, and before surgery has become the only remaining option on the table. The evidence supports intervening once the diagnosis is confirmed and conservative care has been given a fair trial. Waiting longer does not improve outcomes. For the right patient, at the right time, basivertebral nerve ablation can be genuinely practice-changing. That is a meaningful thing to be able to offer.
DISCLOSURE & REFERENCES
This article is for educational purposes and reflects clinical experience and interpretation of published literature. It is not a substitute for individualized medical evaluation. Key references: Fischgrund et al. 2018 (SMART Trial, J Neurosurg Spine); Becker et al. 2021 (5-year outcomes, J Neurosurg Spine); Khalil et al. 2019 (Pain Med); Conger et al. 2021 (Pain Med); Friedly et al. 2021 (comparative effectiveness).
ABOUT THE AUTHOR
Dr. Mahajer is a double board-certified physiatrist and sports medicine physician, fellowship-trained in Interventional Spine & Sports Medicine at the Icahn School of Medicine at Mount Sinai. He is an Assistant Professor of Neuroscience at FIU Herbert Wertheim College of Medicine. He is the Immediate Past President of the American Osteopathic College of Physical Medicine and Rehabilitation (AOCPMR), holds medical licenses in Florida, New York, and California, and has been recognized as a Top Physiatrist and Top Doctor in both Florida and New York.
